Microbial Resources

Status of strains in

HEM Pharma has diverse microbial resources of over 1,200 kinds, and more than 50 strains have been proven to be safe bacteria that meet the microbial safety standards presented by the FDA.

  • Lactobacillus
  • Bifidobacterium
  • Enteroccocus
  • Bacillus
  • Pediococcus
  • Lactococcus
  • Leuconostoc
  • Weissella
  • Clostridium
  • Streptococcus
  • Staphylococcus

Management of
microbial resource

HEM Pharma has a microbial resource management system that enables overall research process and operation of the systematic management, from isolation of microbes, identification of microbes, securing of microbial resources, safety verification, finding of medicines and candidate bacteria for commercialization.

Microbial isolation Securing source separation technology
  • Securing source separation technology that can isolate various types of microbes
  • Currently possessing 1,200 kinds of strains
  • Adding resources through continuous isolation and identification
Microbial identification Identification through physiological, chemical and genetic characteristics
Microbial resource management Microbial resource management system
  • Systematic microbial resource management operation with LIMS(laboratory information management system) developed independently according to the know-how about strain conservation management
Safety verification Strain safety experiment and analysis technology
  • Proceeding other company’s analysis of strains
  • Multiple issuance of COA - For submission to the Korean Ministry of Food and Drug Safety, EFSA of Europe, and US FDA
Candidate bacteria for medicines and commercialization Strains with secured function and safety
  • Possessing more than 90 kinds of strains of functional and medicine candidate
  • Securing the patent rights of the strain itself by completing the patent registration of the strain